United Therapeutics Cash on Hand 2010-2025 | UTHR

United Therapeutics cash on hand from 2010 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • United Therapeutics cash on hand for the quarter ending March 31, 2025 was $3.321B, a 22.66% increase year-over-year.
  • United Therapeutics cash on hand for 2024 was $3.267B, a 9.11% increase from 2023.
  • United Therapeutics cash on hand for 2023 was $2.994B, a 5.47% increase from 2022.
  • United Therapeutics cash on hand for 2022 was $2.839B, a 47.03% increase from 2021.
United Therapeutics Annual Cash on Hand
(Millions of US $)
2024 $3,267
2023 $2,994
2022 $2,839
2021 $1,931
2020 $1,835
2019 $1,486
2018 $1,416
2017 $927
2016 $1,051
2015 $954
2014 $696
2013 $694
2012 $479
2011 $403
2010 $627
2009 $229
United Therapeutics Quarterly Cash on Hand
(Millions of US $)
2025-03-31 $3,321
2024-12-31 $3,267
2024-09-30 $3,327
2024-06-30 $2,972
2024-03-31 $2,708
2023-12-31 $2,994
2023-09-30 $2,876
2023-06-30 $2,679
2023-03-31 $2,863
2022-12-31 $2,839
2022-09-30 $2,616
2022-06-30 $2,255
2022-03-31 $2,268
2021-12-31 $1,931
2021-09-30 $2,000
2021-06-30 $1,968
2021-03-31 $1,731
2020-12-31 $1,835
2020-09-30 $1,581
2020-06-30 $1,561
2020-03-31 $1,545
2019-12-31 $1,486
2019-09-30 $1,570
2019-06-30 $1,786
2019-03-31 $1,605
2018-12-31 $1,416
2018-09-30 $1,238
2018-06-30 $1,213
2018-03-31 $1,257
2017-12-31 $927
2017-09-30 $1,211
2017-06-30 $1,115
2017-03-31 $1,156
2016-12-31 $1,051
2016-09-30 $1,033
2016-06-30 $945
2016-03-31 $975
2015-12-31 $954
2015-09-30 $922
2015-06-30 $440
2015-03-31 $657
2014-12-31 $696
2014-09-30 $768
2014-06-30 $568
2014-03-31 $760
2013-12-31 $694
2013-09-30 $717
2013-06-30 $697
2013-03-31 $671
2012-12-31 $479
2012-09-30 $503
2012-06-30 $392
2012-03-31 $409
2011-12-31 $403
2011-09-30 $695
2011-06-30 $730
2011-03-31 $683
2010-12-31 $627
2010-09-30 $462
2010-06-30 $379
2010-03-31 $293
2009-12-31 $229
2009-09-30 $235
2009-06-30 $220
2009-03-31 $186
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $13.422B $2.877B
United Therapeutics Corporation markets four medicines in the United States to treat pulmonary arterial hypertension (PAH): Remodulin, an injectable formulation of treprostinil, Orenitram, an oral version of treprostinil, Tyvaso, an inhaled version of treprostinil, and Adcirca (tadalafil; also sold by Eli Lilly as Cialis for erectile dysfunction) tablets.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $81.255B 31.25
Zoetis (ZTS) United States $67.231B 25.08
Daiichi Sankyo, - (DSNKY) Japan $46.317B 23.74
Takeda Pharmaceutical (TAK) Japan $45.565B 9.06
BeOne Medicines - (ONC) Cayman Islands $33.509B 0.00
Sandoz Group AG (SDZNY) Switzerland $25.995B 0.00
Summit Therapeutics (SMMT) United States $19.859B 0.00
Merck (MKKGY) Germany $16.905B 12.39
Shionogi (SGIOY) Japan $14.275B 14.30
Neurocrine Biosciences (NBIX) United States $13.280B 45.49
Orion OYJ (ORINY) Finland $11.409B 27.50
IPSEN (IPSEY) France $10.846B 0.00
Stevanato Group S.p.A (STVN) Italy $7.653B 46.80
Corcept Therapeutics (CORT) United States $7.232B 58.79
Grifols, S.A (GRFS) Spain $7.219B 0.00
Ionis Pharmaceuticals (IONS) United States $6.602B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.537B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.204B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.232B 0.00
Hypermarcas (HYPMY) Brazil $2.971B 19.54
Crinetics Pharmaceuticals (CRNX) United States $2.741B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.563B 8.98
NewAmsterdam Pharma (NAMS) Netherlands $2.558B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.536B 13.71
Centessa Pharmaceuticals (CNTA) United Kingdom $2.032B 0.00
Ocular Therapeutix (OCUL) United States $1.872B 0.00
Endo (NDOI) United States $1.813B 0.00
ARS Pharmaceuticals (SPRY) United States $1.743B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.693B 0.00
Evotec AG (EVO) Germany $1.506B 0.00
Dyne Therapeutics (DYN) United States $1.309B 0.00
Guardian Pharmacy Services (GRDN) United States $1.287B 0.00
Harrow (HROW) United States $1.267B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.209B 24.18
Avadel Pharmaceuticals (AVDL) Ireland $1.028B 0.00
Ardelyx (ARDX) United States $1.010B 0.00
Collegium Pharmaceutical (COLL) United States $1.003B 5.41
Enliven Therapeutics (ELVN) United States $0.985B 0.00
Akebia Therapeutics (AKBA) United States $0.922B 0.00
ProKidney (PROK) United States $0.811B 0.00
Xeris Biopharma Holdings (XERS) United States $0.782B 0.00
Cronos Group (CRON) Canada $0.775B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.709B 0.00
KalVista Pharmaceuticals (KALV) United States $0.687B 0.00
Xencor (XNCR) United States $0.628B 0.00
Relay Therapeutics (RLAY) United States $0.621B 0.00
Organogenesis (ORGO) United States $0.605B 0.00
Zevra Therapeutics (ZVRA) United States $0.591B 0.00
Elite Pharmaceuticals (ELTP) United States $0.585B 0.00
Tourmaline Bio (TRML) United States $0.583B 0.00
USANA Health Sciences (USNA) United States $0.564B 11.33
Theravance Biopharma (TBPH) United States $0.552B 0.00
Bioventus (BVS) United States $0.537B 13.62
Oruka Therapeutics (ORKA) United States $0.514B 0.00
Siga Technologies (SIGA) United States $0.501B 10.46
Savara (SVRA) United States $0.453B 0.00
Aquestive Therapeutics (AQST) United States $0.390B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.356B 9.61
AleAnna (ANNA) United States $0.354B 0.00
Nanobiotix S.A (NBTX) France $0.327B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.314B 0.00
Altimmune (ALT) United States $0.311B 0.00
Aldeyra Therapeutics (ALDX) United States $0.305B 0.00
Esperion Therapeutics (ESPR) United States $0.291B 0.00
Nektar Therapeutics (NKTR) United States $0.284B 0.00
Heron Therapeutics (HRTX) United States $0.282B 0.00
Nature's Sunshine Products (NATR) United States $0.270B 24.83
OmniAb (OABI) United States $0.239B 0.00
Larimar Therapeutics (LRMR) United States $0.226B 0.00
MediWound (MDWD) Israel $0.214B 0.00
Galectin Therapeutics (GALT) United States $0.209B 0.00
4D Molecular Therapeutics (FDMT) United States $0.202B 0.00
Lyell Immunopharma (LYEL) United States $0.191B 0.00
China SXT Pharmaceuticals (SXTC) China $0.179B 0.00
Journey Medical (DERM) United States $0.177B 0.00
Liminatus Pharma (LIMN) United States $0.174B 0.00
Aclaris Therapeutics (ACRS) United States $0.168B 0.00
Profound Medical (PROF) Canada $0.164B 0.00
Avita Medical (RCEL) United States $0.152B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.144B 0.00
Korro Bio (KRRO) United States $0.142B 0.00
Lexeo Therapeutics (LXEO) United States $0.136B 0.00
Protara Therapeutics (TARA) United States $0.128B 0.00
Inhibikase Therapeutics (IKT) United States $0.126B 0.00
Cardiol Therapeutics (CRDL) Canada $0.121B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.113B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Cassava Sciences (SAVA) United States $0.107B 0.00
VAXART, INC (VXRT) United States $0.091B 0.00
Fractyl Health (GUTS) United States $0.089B 0.00
Vivani Medical (VANI) United States $0.089B 0.00
Achieve Life Sciences (ACHV) Canada $0.088B 0.00
Champions Oncology (CSBR) United States $0.088B 20.06
Metagenomi (MGX) United States $0.088B 0.00
Nutriband (NTRB) United States $0.084B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Surrozen (SRZN) United States $0.079B 0.00
PMV Pharmaceuticals (PMVP) United States $0.075B 0.00
Context Therapeutics (CNTX) United States $0.074B 0.00
Dominari Holdings (DOMH) United States $0.071B 0.00
Avalo Therapeutics (AVTX) United States $0.071B 0.00
Pyxis Oncology (PYXS) United States $0.071B 0.00
Rafael Holdings (RFL) United States $0.070B 0.00
Inotiv (NOTV) United States $0.070B 0.00
Assertio Holdings (ASRT) United States $0.068B 0.00
Wellgistics Health (WGRX) United States $0.067B 0.00
Telomir Pharmaceuticals (TELO) United States $0.061B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
DURECT (DRRX) United States $0.058B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.058B 0.00
Unicycive Therapeutics (UNCY) United States $0.056B 0.00
BioNxt Solutions (BNXTF) Canada $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.052B 38.78
ElectroCore (ECOR) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.050B 0.00
NRx Pharmaceuticals (NRXP) United States $0.050B 0.00
Gain Therapeutics (GANX) United States $0.047B 0.00
Prelude Therapeutics (PRLD) United States $0.047B 0.00
Jupiter Neurosciences (JUNS) United States $0.047B 0.00
Klotho Neurosciences (KLTO) United States $0.044B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
Mural Oncology (MURA) Ireland $0.041B 0.00
Karyopharm Therapeutics (KPTI) United States $0.036B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
Enlivex Therapeutics (ENLV) Israel $0.034B 0.00
Plus Therapeutics (PSTV) United States $0.032B 0.00
Incannex Healthcare (IXHL) Australia $0.031B 0.00
Iterum Therapeutics (ITRM) Ireland $0.030B 0.00
FibroGen (FGEN) United States $0.029B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.027B 0.00
Vivos Therapeutics (VVOS) United States $0.026B 0.00
Scienture Holdings (SCNX) United States $0.026B 0.00
Cosmos Health (COSM) United States $0.024B 0.00
Natural Alternatives (NAII) United States $0.023B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.023B 0.00
VYNE Therapeutics (VYNE) United States $0.022B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
CASI Pharmaceuticals (CASI) China $0.019B 0.00
Mannatech (MTEX) United States $0.018B 0.00
BioLineRx (BLRX) Israel $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Carisma Therapeutics (CARM) United States $0.014B 0.00
Minerva Neurosciences (NERV) United States $0.014B 2.38
TherapeuticsMD (TXMD) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
BioVie (BIVI) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ainos (AIMD) United States $0.010B 0.00
TransCode Therapeutics (RNAZ) United States $0.010B 0.00
Lyra Therapeutics (LYRA) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Aptorum Group (APM) United Kingdom $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Qualigen Therapeutics (QLGN) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 10.10
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00